Sign in
Taking people in United StatesNo phase

Developing better MRI scans for heart and blood vessel problems

Tries out new MRI techniques to picture the heart in adults and volunteers.

Key facts

Who runs it
National Heart, Lung, and Blood Institute (NHLBI)
Where
Bethesda and Washington D.C., United StatesSee the 2 sites
Trial code
Registry title
Technical Development of Cardiovascular Magnetic Resonance Imaging
Status
Recruiting
People taking part
3,400 people, planned
Started
8 Apr 2024
Expected to end
31 Dec 2031
Type of study
Observational, 2 groups
Record updated
9 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who are having a heart or blood vessel MRI for medical reasons, and also for healthy volunteers. It tests new MRI methods.

Age
18 years and older
Sex
Men and women can join.
Disease stage
Group A: people having a clinically indicated heart or blood vessel MRI, for example for known or suspected heart failure, cardiomyopathy, coronary artery disease, valve disease, congenital heart disease or aortic disease. Group B: healthy volunteers.

Main reasons for not taking part

  • Cannot have an MRI because of implants such as aneurysm clips, a pacemaker or defibrillator, or a cochlear implant, unless cleared as safe for MRI
  • Kidney function eGFR 30 mL/min/1.73m(2) or lower, or known allergy to contrast dye, for scans using that dye
  • Pregnant women
  • Healthy volunteers with a major illness such as diabetes or heart disease, or who currently smoke
  • People who cannot make decisions for themselves (healthy volunteer group)

The registry criteria, word for word

Show all 9 criteriaShow less

Who cannot take part

  • An individual who meets any of the following criteria will be excluded from participation in this study:; Unable to undergo magnetic resonance imaging because of:; Central nervous system aneurysm clips; Implanted neural stimulator; Implanted cardiac pacemaker or defibrillator; Cochlear implant; Ocular foreign body (e.g. metal shavings); Implanted Insulin pump; Metal shrapnel or bullet; unless any of the above objects have been cleared as safe for MRI according to the assessment present as clinical routine at the site; 2.For examinations that include contrast injection of GBCA:; -- renal excretory dysfunction, estimated glomerular filtration rate <= 30 mL/min/1.73m(2) body surface area.(estimated glomerular filtration rate is only determined according to the institutional guidelines of patients at risk of renal dysfunction and may also depend upon the dose of GBCA administered); -- Known allergic reactions to GBCA; -- Subjects may still be invited for non-contrast enhanced examinations or undergo MR examination with ferumoxytol as contrast agent; . For examinations that include contrast injection of ferumoxytol; -- Known allergic reactions to ferumoxytol or to mannitol excipient; For subjects with a planned pharmacological stress test with adenosine or regadenoson the following contraindications will be considered as exclusion criteria:; --Bronchospastic lung disease with ongoing wheezing or history of significant reactive airway disease; --Second- or third- degree atrioventricular blood, sinus node disease without a functioning MR conditional pacemaker; --Systolic blood pressure < 90 mmHg; --Uncontrolled hypertension (systolic BP > 200 mmHg or diastolic BP > 110 mmHg); --Recent (< 48hr) use of dipyridamole of dipyridamole- containing medications; --Known hypersensitivity to adenosine or regadenoson; Unstable angina, acute coronary syndrome, or less than 2- 4 days after an acute myocardial infarction; For regadenoson only: seizure disorder as regadenoson may lower seizure threshold. Aminophylline should not be used in cases of seizures associated with Regadenoson; Pregnant Women; Lactating Women for administration of GBCA unless the subjects is willing to discard the milk for 24 hours after receiving gadolinium; In addition, the following exclusion criteria pertains to Group B, healthy volunteers to be considered for reference values:; Known history of major illness, including, but not limited to having a hypertension diagnosis in need of anti-hypertensive medication, myocardial infarction, diabetes, familial hypercholesterolemia, cardiomyopathy, congenital heart disease, moderate or severe valvular disease, cerebrovascular insult or peripheral vascular disease, symptoms of angina or dyspnea, current smoker; Decisionally impaired individuals

Other criteria

  • INCLUSION CRITERIA:; Group A: In order to be eligible to participate in this study, an individual must meet all of the following criteria:
  • Provision of signed and dated informed consent form by subject
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Male or female, 18 years or older
  • Subjects undergoing a clinically indicated MRI examination. Examples of medical indications include known or suspected heart failure or cardiomyopathy, chest pain with known or suspected coronary artery disease, unexplained dyspnea, valve disease, known or suspected congenital heart disease, cardiac masses and known or suspected aortic disease, exposure to cardiotoxic drugs, and systemic illnesses with known associated cardiovascular involvement; Group B, Healthy volunteers enrolled for developmental testing and establishing reference values for the custom pulse sequences. In order to be eligible to participate in this study, an individual must meet all of the following criteria:
  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • Male or female, 18 years or older

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 100 years old?

Where in United States

  • National Institutes of Health Clinical CenterBethesda, United StatesContact: Stacian D Awojoodu, C.R.N.P.Taking people
  • MedStar Washington Hospital CenterWashington D.C., United StatesContact: James H. Boscoe, MA, CIPTaking people

About the trial

What the trial wants to find out

Background:

Read full original descriptionShow less

In the U.S., over 6.5 million people have heart failure. Researchers want to develop new testing methods for cardiovascular problems using magnetic resonance imaging (MRI) to improve the clinical diagnosis and management of people with heart failure.

Objective:

To develop and test new methods for imaging the heart and blood vessels using MRI.

Eligibility:

People ages 18 years and older who are having an MRI of their heart or blood vessels. Healthy volunteers are also needed.

Design:

Participants will be screened with a medical history.

Participants will have a physical exam and blood tests. They will have an electrocardiogram (ECG) to measure the heart s electrical activity. Then they will have their scheduled MRI scan. The MRI scanner is a large, hollow tube. Participants will lie on a table that moves in and out of the tube. During the MRI, they may have contrast dye injected through an intravenous line inserted into their arm or hand. ECG may be used to monitor their heartbeat or coordinate pictures with their heartbeat. A flexible belt may be used to monitor their breathing. A finger probe may be used to track their heart rate and/or oxygenation level. Their blood pressure may be measured. Pictures may be taken of their blood vessels, heart, and lungs before, during, and after they get medicine to increase blood flow. They may lie flat and pedal a stress bicycle to increase their heart rate.

Participation will last for 5 years. During that time, participants may receive a yearly survey about their health. They may be contacted for an optional follow-up MRI within 2 years of their MRI.

The 2 groups in the trial

  • Affected participants

    Participants with a clinically indicated referral for cardiac MRI

  • Healthy participants

    Healthy individuals of various ethnicities to serve as reference ranges

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Technical Development of Cardiovascular MRI
Plain-language title
Developing better MRI scans for heart and blood vessel problemsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT04927429, who can take part
Record updated
9 October 2026